These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24116137)

  • 1. Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.
    Peng YH; Li JJ; Xie FW; Chen JF; Yu YH; Ouyang XN; Liang HJ
    PLoS One; 2013; 8(10):e76693. PubMed ID: 24116137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
    Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
    Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.
    Roth AD; Delorenzi M; Tejpar S; Yan P; Klingbiel D; Fiocca R; d'Ario G; Cisar L; Labianca R; Cunningham D; Nordlinger B; Bosman F; Van Cutsem E
    J Natl Cancer Inst; 2012 Nov; 104(21):1635-46. PubMed ID: 23104212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
    Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
    Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.
    Weirauch U; Beckmann N; Thomas M; Grünweller A; Huber K; Bracher F; Hartmann RK; Aigner A
    Neoplasia; 2013 Jul; 15(7):783-94. PubMed ID: 23814490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu HT; Wang N; Wang X; Li SL
    J Surg Oncol; 2010 Nov; 102(6):683-8. PubMed ID: 20544717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
    Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
    Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of Src activation in stage II-III colon cancer.
    Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
    Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.
    Li X; Guo J; Ding AP; Qi WW; Zhang PH; Lv J; Qiu WS; Sun ZQ
    Technol Cancer Res Treat; 2017 Aug; 16(4):428-434. PubMed ID: 27432118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Adenylyl Cyclase 9 Expression Is a Potential Prognostic Biomarker for Patients with Colon Cancer.
    Yi H; Wang K; Jin JF; Jin H; Yang L; Zou Y; Du B; Liu X
    Med Sci Monit; 2018 Jan; 24():19-25. PubMed ID: 29292367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
    Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
    Ng K; Ogino S; Meyerhardt JA; Chan JA; Chan AT; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Bertagnolli MM; Venook AP; Fuchs CS
    J Natl Cancer Inst; 2011 Oct; 103(20):1540-51. PubMed ID: 21849660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB.
    Li CY; Li BX; Liang Y; Peng RQ; Ding Y; Xu DZ; Zhang X; Pan ZZ; Wan DS; Zeng YX; Zhu XF; Zhang XS
    J Transl Med; 2009 Jul; 7():56. PubMed ID: 19583834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.